Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
InferLink is an artificial intelligence research and consulting firm specializing in advanced data science, machine learning, natural language processing, and large language models. The company has developed software that automates extraction of structured information from scientific literature—including biomedical and clinical trial texts—using deep learning. Their technology has been applied to automate systematic reviews, meta-analysis, and validation of scientific claims. A notable spin-off using their technology in the pharmaceutical industry was Evid Science/Evid Science Inc., which was acquired by Genesis Research[1][6]. InferLink itself does not develop therapeutic drugs or biologics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on InferLink.